Specialty
Certifications
Advanced Heart Failure and Transplant Cardiology
Cardiovascular Disease
Clinical Focus
Education
MD, Georgetown Univ. School of Medicine
Beth Israel Deaconess Hospital
MedicineInternship, Internal Medicine
Beth Israel Deaconess Medical Center- Harvard Medical SchoolResidency, Internal Medicine
Beth Israel Deaconess Medical Center- Harvard Medical SchoolFellowship, Cardiology
Columbia-Presbyterian Medical CenterFellowship, Cardiology
Columbia University
Biography
Dr. Pinney serves as Director of the Advanced Heart Failure and Cardiac Transplant Program at Mount Sinai Medical Center, and as Director of the Pulmonary Hypertension Program.
His clinical interests center upon the care of a broad spectrum of patients with advanced cardiovascular disease. These include patients with heart failure in need of heart transplantation or mechanical circulatory support devices; patients with pulmonary hypertension; and patients with congenital heart disease, in particular those in need of organ transplantation including combined heart-lung transplant.
Dr. Pinney is an active clinical researcher whose primary focus is the understanding and treatment of cardiac allograft vasculopathy. This condition affects approximately half of all transplant recipients by their fifth year and limits the long-term success of heart transplantation. He is the author of more than 20 publications in peer-reviewed journals and is frequent lecturer on the topic of cardiovascular disease.
He received his medical degree from Georgetown University and completed a residency and chief residency in internal medicine at Beth Israel Deaconess Hospital in Boston. He spent six years at Columbia University where he completed fellowships in cardiology, heart failure and cardiac transplantation before joining the faculty in the Division of Circulatory Physiology. He moved to Mount Sinai in 2004.
Publications
Nagarsheth NP, Pinney S, Bassily-Marcus A, Anyanwu A, Friedman L, Beilin Y. Successful placement of a right ventricular assist device for treatment of a presumed amniotic fluid embolism. Anesth Analg 2008; 107: 962-964.
Anyanwu AC, Fischer GW, Plotkina I, Pinney S, Adams DH. Off-pump implant of the Jarvik 2000 ventricular assist device through median sternotomy. Ann Thorac Surg 2007; 84: 1405-1407.
Lubitz SA, Pinney S, Wisnivesky JP, Gass A, Baran DA. Statin therapy is associated with a reduced risk of chronic renal failure after cardiac transplantation. J Heart Lung Transplant 2007; 26: 264-272.
Winslow RD, Pinney S, Fuster V. Impact of implantable cardioverter-defibrillator trials on clinical management of patients with heart failure. Nat Clin Pract Cardiovasc Med 2006; 3: 86-93.
Salzberg SP, Filsoufi F, Anyanwu A, von Harbou K, Gass A, Pinney SP, Carpentier A, Adams DH. High-risk mitral valve surgery: perioperative hemodynamic optimization with nesiritide (BNP). Ann Thorac Surg 2005; 80: 502-506.
Mckay M, Pinney S, Gorwara S, Burke EM, Sciacca RR, Apfelbaum M, Mancini D, Itescu S, Rabbani LE. Anti-HLA antibodies are associated with restenosis after percutaneous coronary intervention for cardiac allograft vasculopathy. Transplantation 2005; 79: 1581-1587.
Pinney S, Cheema FH, Hammond K, Chen JM, Edwards NM, Mancini D. Acceptable recipient outcomes with the use of hearts from donors with hepatitis-B core antibodies. J Heart Lung Transplant 2005; 24: 34-37.
Pinney SP, Mancini D. Cardiac allograft vasculopathy: advances in understanding its pathophysiology, prevention and treatment. Curr Opin Cardiol 2004; 19: 170-176.
Mancini DM, Pinney SP, Burkhoff D, Lamanca J, Itescu S, Burke E, Edwards N, Oz M, Marks AR. Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003; 108: 48-53.
Pinney SP, Chen HJ, Liang D, Wang X, Schwartz A, Rabbani LE. Minocycline inhibits smooth muscle cell proliferation, migration and neointima formation after arterial injury.. J Cardiovasc Pharmacol 2003; 42: 469-476.
Clinical Trials
- 24 Month, Multicenter, Randomized, Open-Label Non-Inferiority Study of Efficacy and Safety Comparing Two Exposures of Concentration-Controlled Certican With Reduced Neoral Versus 3.0g MMF With Standard Dose Neoral In De Novo Heart Transplant Recipients
- Observational Study of Alloimmunity in Cardiac Trans Pts
- Tolvaptan on Hemodynamic Parameters in Pts. w/ Heart Failure
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr. Pinney did not report having any of the following types of financial relationships with industry during 2012 and/or 2013: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.
Guggenheim Pavilion Floor 6th Floor Room 6W-271
1190 Fifth Avenue
New York, NY 10029
5 East 98th Street, 3rd Floor
New York, NY 10029
Fax: 212-289-5971
5 East 98th Street - 3rd floor
New York, NY 10029
Fax: 212-289-5971
- Monday 1:00pm - 3:45pm
- Tuesday 1:00pm - 3:45pm
- Wednesday
- Thursday 8:00am - 12:00pm
- Friday 9:00am - 11:45am
- Aetna U.S. Healthcare
- Beech Street
- Best Doctor
- CarePlus, LLC
- CenterCare, Inc.
- Cigna
- Devon Health Services
- Empire Blue Cross/Blue Shield
- Fidelis Care NY
- First Health
- Group Health Insurance, Inc.
- Health Insurance Plan (HIP)
- HealthPlus, Inc.
- Healthfirst
- Horizon Healthcare
- Island Group
- Local 1199
- Magnacare
- Medicaid
- Medicaid New Jersey
- Medicare
- MetroPlus Health Plan
- MultiPlan, Inc.
- Neighborhood Health Providers, LLC
- Oxford Health Plans
- PHS/Healthnet/Guardian
- Private Healthcare Systems (PHCS)
- Travel Care Services
- United Health Care Empire Plan
- United Healthcare
- Vytra
- WellCare of New York, Inc.
- Master Card
- Visa
- Cash